Ameritas Investment Partners’s Impax Laboratories, Inc. IPXL Stock Holding History

Ameritas Investment Partners’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6,324	Closed	-$123K	–	3148
2018 Q1	$123K	Hold	6,324	–	–	0.01%	1366
2017 Q4	$105K	Hold	6,324	–	–	﹤0.01%	1477
2017 Q3	$136K	Hold	6,324	–	–	0.01%	1274
2017 Q2	$102K	Hold	6,324	–	–	﹤0.01%	1457
2017 Q1	$80K	Buy	+6,324	New	+$76.4K	﹤0.01%	1559
2016 Q1	–	Sell	-5,534	Closed	-$237K	–	1200
2015 Q4	$237K	Buy	+5,534	New	+$221K	0.02%	872
2015 Q3	–	Sell	-5,534	Closed	-$254K	–	1185
2015 Q2	$254K	Sell	5,534 -744	-12%	-$35.3K	0.02%	879
2015 Q1	$294K	Buy	+6,278	New	+$250K	0.02%	837

Ameritas Investment Partners's IPXL Position: Q2 2018 in Review

Ameritas Investment Partners sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 6,324 shares — an estimated $123K sold.

Ameritas Investment Partners first reported a position in IPXL in Q1 2015 and held it in 8 quarters. The position peaked at $294K in Q1 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Ameritas Investment Partners reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Ameritas Investment Partners sold 6,324 Impax Laboratories, Inc. shares in Q2 2018, an estimated $123K.
Ameritas Investment Partners first reported a position in Impax Laboratories, Inc. in Q1 2015 and held it in 8 quarters.
Ameritas Investment Partners's Impax Laboratories, Inc. position peaked at $294K in Q1 2015.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Ameritas Investment Partners's 13F filing for Q2 2018, filed 13 Aug 2018.